Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Mistry M and Nasjletti A | Role of TXA2 in the pathogenesis of severe angiotensin II-salt hypertension. | 1989 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2526469 |
Koshihara Y and Fukuda M | Appearance of metabolic activities for arachidonate during development of mouse embryos. | 1989 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2526512 |
Fuse I and Tai HH | Regulation of arachidonate release by G-proteins and protein kinase C in human platelets. | 1989 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2526540 |
Houtz P and Tai HH | Enzyme immunoassay of thromboxane B2 using immobilized hapten and enzyme amplification. | 1989 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2526560 |
Hayashi Y et al. | Radioimmunoassay of 11-dehydro-thromboxane B2 using monoclonal antibody. | 1989 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2526561 |
Knospe J et al. | Derivatization of prostaglandins to corresponding anilides and analysis by HPLC. | 1989 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2526562 |
Nowak J and FitzGerald GA | In vivo formation of prostacyclin and thromboxane A2 at the site of platelet-vascular interaction in humans. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2959050 |
De Caterina R et al. | Characteristics of thromboxane production by the isolated-perfused rat heart. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2959082 |
Samhoun MN et al. | Differential effect of vasoactive intestinal peptide on contractions induced by leukotriene D4, histamine, and acetylcholine in guinea pig lung parenchyma in vitro. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960144 |
Granström E and Kumlin M | Assay of thromboxane production in biological systems: reliability of TXB2 versus 11-dehydro-TXB2 as targets for measurement. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960161 |
Lecompte T et al. | Radioimmunoassay for 11-dehydro-thromboxane B2 using an iodinated ligand: preliminary applications to human fluids. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960162 |
Catella F et al. | Analysis of multiple thromboxane metabolites in plasma and urine. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960166 |
Miyazaki H et al. | Microdetermination of prostaglandins and thromboxane B2 by gas chromatography/high-resolution selected-ion monitoring. | 1985 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2936139 |
Kobayashi N et al. | Effect of changes in prostaglandin synthesis by platelets and vessel wall on the formation of arterial thrombosis in rabbits. | 1985 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2936159 |
Westwick J et al. | Inhibition of thromboxane formation prevents endotoxin-induced renal fibrin deposition in jaundiced rats. | 1983 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:6221642 |
Kangasaho M et al. | Formation of thromboxane B2 by platelets and concentrations of thromboxane B2 and 6-keto-prostaglandin F1 alpha in plasma after acute ethanol ingestion. | 1983 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:6303086 |
Cifone MG et al. | Stimulatory effect of hr tumor necrosis factor on TxB2 release by polymorphonuclears and macrophages. | 1986 | Agents Actions | pmid:3825754 |
Carr DP et al. | Comparison of the systemic inhibition of thromboxane synthesis, anti-inflammatory activity and gastro-intestinal toxicity of non-steroidal anti-inflammatory drugs in the rat. | 1986 | Agents Actions | pmid:3825757 |
de Clerck F et al. | Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982. | 1994 | Agents Actions | pmid:7725978 |
De Clerck F et al. | Platelet activation by endogenous 5-hydroxytryptamine and histamine released by mast cell degranulation with compound 48/80 in the rat. | 1983 | Agents Actions | pmid:6858790 |